ReviewOpen forum infectious diseases2026
Integrating Cervical Cancer Prevention into HIV Services in Sub-Saharan Africa: A Narrative Review Addressing the Dual Burden Among Women.
Review in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Women with HIV face a higher risk of cervical cancer. This review synthesizes evidence on precancerous cervical lesions among women with HIV in sub-Saharan Africa (SSA), regional differences, risk factors, and approaches to integrating cervical cancer prevention into HIV services. Methods: We conducted a comprehensive literature search across PubMed, Embase, Scopus, and Web of Science databases through December 2025 and identified studies evaluating the prevalence of precancerous cervical lesions among women with HIV in SSA. It highlights prevalence, ongoing global efforts, and integration strategies specific to SSA. Results: The prevalence of precancerous cervical lesions among women with HIV in SSA is higher in Tanzania (71.8%), and Kenya (42%), eastern countries than from western (Nigeria, 26.6%) or southern countries (South Africa, 23.2%), influenced by the distribution of human papillomavirus (HPV) genotypes, including higher-risk HPV (HR-HPV) such as HPV 35, which is not targeted by the HPV vaccine. Conclusions: Given the increased risk among women with HIV and the substantial burden in SSA, evidence suggests that integrating HPV-based cervical cancer screening and vaccination into HIV care platforms could help close the prevention gap and reduce the dual burden among women with HIV in SSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.